<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
		>

<channel>
	<title>IMA Forums | FLCCC_denisev | Activity</title>
	<link>https://imahealth.org/forums/members/9f2aa4d2/activity/</link>
	<atom:link href="https://imahealth.org/forums/members/9f2aa4d2/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for FLCCC_denisev.</description>
	<lastBuildDate>Fri, 03 Apr 2026 18:58:35 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=2.10.0</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
		
								<item>
				<guid isPermaLink="false">17dab7ea9ab6c82dd1b04ce2bb0b57ab</guid>
				<title>FLCCC_denisev replied to the discussion Startup Secures $7.1M to Revolutionize Diagnostics with Liquid Biopsy Tech in the forum General</title>
				<link>https://imahealth.org/forums/groups/public-forum/forum/discussion/startup-secures-7-1m-to-revolutionize-diagnostics-with-liquid-biopsy-tech/#post-7445</link>
				<pubDate>Mon, 27 Jan 2025 16:36:33 -0500</pubDate>

									<content:encoded><![CDATA[<p class = "activity-discussion-title-wrap"><a href="https://imahealth.org/forums/groups/public-forum/forum/discussion/startup-secures-7-1m-to-revolutionize-diagnostics-with-liquid-biopsy-tech/#post-7445"><span class="bb-reply-lable">Reply to</span> Startup Secures $7.1M to Revolutionize Diagnostics with Liquid Biopsy Tech</a></p> <div class="bb-content-inr-wrap"><p>Hi Michael</p>
<p>Another company in the US already doing this, I have used them for a client for a blood test to confirm if there were any NSCLC tumor ctDNA in the blood after the client had: surgical resection for Stage 4 NSCLC, 4 rounds of chemotherapy, ivermectin, and also herbal treatments I prescribed for her alongside all of this.  Answer -&hellip;</p>
<p><span class="activity-read-more" id="activity-read-more-25503"><a href="https://imahealth.org/forums/groups/public-forum/forum/discussion/startup-secures-7-1m-to-revolutionize-diagnostics-with-liquid-biopsy-tech/#post-7445" rel="nofollow"> Read more</a></span></p>
<div class="bb-link-preview-container"><div class="bb-link-preview-image"><div class="bb-link-preview-image-cover"><a href="https://www.natera.com/oncology/signatera-advanced-cancer-detection/patients/signatera-for-lung-cancer/" target="_blank"><img src="https://imahealth.org/forums/wp-content/uploads/sites/2/2025/01/Natera-social.jpg" /></a></div></div><div class="bb-link-preview-info"><p class="bb-link-preview-link-name">natera.com</p><p class="bb-link-preview-title"><a href="https://www.natera.com/oncology/signatera-advanced-cancer-detection/patients/signatera-for-lung-cancer/" target="_blank" rel="nofollow">Signatera for Lung Cancer</a></p><div class="bb-link-preview-excerpt"><p>Signatera™ is a blood test that measures cDNA to monitor lung cancer recurrence. Click here to learn more about how it works.</p></div></div></div></div>]]></content:encoded>
				
				
							</item>
		
	</channel>
</rss>
		